Raya to Buy 30% of 10th Ramadan Drug Manufacturing

Raya Holding Co., an Egyptian information technology firm, said its board approved buying a 30 percent stake in 10th of Ramadan Drug Manufacturing valued at as much as 214.8 million Egyptian pounds ($37 million).

The company will buy 120,000 shares at a maximum price of 1,789.93 Egyptian pounds per share of the drugmaker, Chairman and Chief Executive Officer Medhat Khalil said in a telephone interview today.

“We think this factory has huge potential, especially after we are able to modernize it,” Khalil said.

Raya shares gained as much as 1.8 percent to 6.1 pounds before trading 0.2 percent higher at 11:48 a.m. in Cairo. That valued Raya at 373 million pounds.

To contact the reporter on this story: Ahmed A Namatalla in Cairo at anamatalla@bloomberg.net

To contact the editor responsible for this story: Mahmoud Kassem at mkassem1@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.